Ranbaxy Laboratories
BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | Pharmaceuticals
| Profit & Loss account |
------------------- in Rs. Cr. ------------------- |
|
Dec '03 |
Dec '04 |
Dec '05 |
Dec '06 |
Dec '07 |
 |
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Income |
|
|
|
|
| Sales Turnover |
3,888.97 |
3,865.86 |
3,727.05 |
4,218.98 |
4,344.39 |
| Excise Duty |
72.03 |
74.58 |
86.56 |
53.86 |
51.37 |
| Net Sales |
3,816.94 |
3,791.28 |
3,640.49 |
4,165.12 |
4,293.02 |
| Other Income |
116.29 |
64.78 |
122.25 |
-28.65 |
551.13 |
| Stock Adjustments |
24.43 |
82.82 |
30.96 |
44.70 |
40.66 |
| Total Income |
3,957.66 |
3,938.88 |
3,793.70 |
4,181.17 |
4,884.81 |
| Expenditure |
|
|
|
|
| Raw Materials |
1,505.11 |
1,566.68 |
1,567.55 |
1,708.23 |
1,861.17 |
| Power & Fuel Cost |
53.79 |
62.67 |
69.55 |
80.70 |
90.35 |
| Employee Cost |
244.17 |
324.01 |
298.38 |
328.45 |
420.04 |
| Other Manufacturing Expenses |
48.04 |
68.68 |
67.09 |
79.52 |
82.60 |
| Selling and Admin Expenses |
966.60 |
1,143.13 |
1,339.12 |
1,234.42 |
1,341.03 |
| Miscellaneous Expenses |
108.01 |
76.28 |
144.32 |
146.23 |
123.90 |
| Preoperative Exp Capitalised |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Expenses |
2,925.72 |
3,241.45 |
3,486.01 |
3,577.55 |
3,919.09 |
|
Dec '03 |
Dec '04 |
Dec '05 |
Dec '06 |
Dec '07 |
|
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Operating Profit |
915.65 |
632.65 |
185.44 |
632.27 |
414.59 |
| PBDIT |
1,031.94 |
697.43 |
307.69 |
603.62 |
965.72 |
| Interest |
8.08 |
10.98 |
26.41 |
58.44 |
93.43 |
| PBDT |
1,023.86 |
686.45 |
281.28 |
545.18 |
872.29 |
| Depreciation |
69.67 |
81.85 |
101.33 |
106.75 |
118.73 |
| Other Written Off |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Profit Before Tax |
954.19 |
604.60 |
179.95 |
438.43 |
753.56 |
| Extra-ordinary items |
2.30 |
26.74 |
12.72 |
19.34 |
35.46 |
| PBT (Post Extra-ord Items) |
956.49 |
631.34 |
192.67 |
457.77 |
789.02 |
| Tax |
161.59 |
99.87 |
-22.34 |
62.43 |
156.69 |
| Reported Net Profit |
794.78 |
527.52 |
212.04 |
380.54 |
617.72 |
| Total Value Addition |
1,420.62 |
1,674.77 |
1,918.46 |
1,869.31 |
2,057.93 |
| Preference Dividend |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Equity Dividend |
315.63 |
316.26 |
316.67 |
316.89 |
317.15 |
| Corporate Dividend Tax |
40.44 |
44.04 |
44.41 |
44.44 |
53.90 |
| Per share data (annualised) |
|
|
|
|
| Shares in issue (lakhs) |
1,855.44 |
1,858.91 |
3,724.42 |
3,726.87 |
3,730.71 |
| Earning Per Share (Rs) |
42.84 |
28.38 |
5.69 |
10.21 |
16.56 |
| Equity Dividend (%) |
170.00 |
170.00 |
170.00 |
170.00 |
170.00 |
| Book Value (Rs) |
125.03 |
134.85 |
63.82 |
63.03 |
68.01 |
|
|
| Source : Asian CERC |
|
Offline
